Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Pathologic Complete Response × 130-nm albumin-bound paclitaxel × Clear all

Sponsor

Conditions

Pancreatic Neoplasms 39 Carcinoma, Non-Small-Cell Lung 31 Breast Neoplasms 29 Triple Negative Breast Neoplasms 15 Neoplasms 13 Neoplasm Metastasis 10 Carcinoma 9 Adenocarcinoma 8 Lung Neoplasms 7 Colorectal Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 5 Pancreatic Diseases 5 Head and Neck Neoplasms 5 Carcinoma, Squamous Cell 5 Parkinson Disease 4, Autosomal Dominant Lewy Body 4 Neoplasms by Site 4 Digestive System Neoplasms 4 Digestive System Diseases 4 Pancreatic Adenocarcinoma 3 Neoplasms by Histologic Type 3 Melanoma 3 Endocrine System Diseases 3 Endocrine Gland Neoplasms 3 Cholangiocarcinoma 3 Carcinoma, Pancreatic Ductal 3 Carcinoma, Ovarian Epithelial 3 Uveal Melanoma 2 Urinary Bladder Neoplasms 2 Tongue Neoplasms 2 Stomach Neoplasms 2

Interventions

temsirolimus 1 sargramostim 1 ruxolitinib 1 rucaparib 1 pazopanib 1 olaparib 1 eltrombopag 1 cc-486 1 Surveys and Questionnaires 1 Nivolumab 1 Monatide (IMS 3015) 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Doxorubicin 1 Docetaxel 1 Diphenhydramine 1 Cytarabine 1 Cyclophosphamide 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡